173 related articles for article (PubMed ID: 12100096)
21. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
22. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
[TBL] [Abstract][Full Text] [Related]
23. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
24. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
25. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases.
Zanella A; Bianchi P; Iurlo A; Boschetti C; Taioli E; Vercellati C; Zappa M; Fermo E; Tavazzi D; Sampietro M
Blood Cells Mol Dis; 2001; 27(3):653-61. PubMed ID: 11482880
[TBL] [Abstract][Full Text] [Related]
26. Association of familial pernicious anaemia and hereditary haemochromatosis.
Bonafoux B; Henry L; Delfour C; Arnaud A; Brun S; Mercier E; Jourdan E; Carillo S; Funakoshi N; Bureau JP; Blanc P; Lavabre-Bertrand T
Acta Haematol; 2008; 119(1):12-4. PubMed ID: 18176074
[TBL] [Abstract][Full Text] [Related]
27. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
28. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
29. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
30. Impact of HLA-H mutations on iron stores in healthy elderly men and women.
Garry PJ; Montoya GD; Baumgartner RN; Liang HC; Williams TM; Brodie SG
Blood Cells Mol Dis; 1997 Aug; 23(2):277-87. PubMed ID: 9410471
[TBL] [Abstract][Full Text] [Related]
31. Chronic daily headache in hereditary hemochromatosis treated by venesection.
Gaul C; Krummernerl P; Tamke B; Kornhuber M
Headache; 2007 Jun; 47(6):926-8. PubMed ID: 17578548
[TBL] [Abstract][Full Text] [Related]
32. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
33. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
[TBL] [Abstract][Full Text] [Related]
34. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
35. Clinical expression of C282Y homozygous HFE haemochromatosis at 14 years of age.
Rossi E; Wallace DF; Subramaniam VN; St Pierre TG; Mews C; Jeffrey GP
Ann Clin Biochem; 2006 May; 43(Pt 3):233-6. PubMed ID: 16704763
[TBL] [Abstract][Full Text] [Related]
36. Dual diagnoses of hereditary hyperferritinaemia-cataract syndrome and hereditary haemochromatosis.
Hughes M; Vosylius P
Clin Lab Haematol; 2006 Oct; 28(5):357-9. PubMed ID: 16999731
[TBL] [Abstract][Full Text] [Related]
37. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
[TBL] [Abstract][Full Text] [Related]
38. Relation between HFE mutations and mild iron-overload expression.
Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
[TBL] [Abstract][Full Text] [Related]
40. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
